Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations
Authors:
- Cheng SunCSCheng Sun
- Weihua XiaoWXWeihua Xiao
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Molecular signatures of T-cell inhibition in HIV-1 infectionRetrovirology, 2013
- Programmed Death Ligand 2 in Cancer-Induced Immune SuppressionJournal of Immunology Research, 2012
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune EscapeCancer Research, 2012
- Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour ActivityPLOS ONE, 2011
- PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in miceJournal of Experimental Medicine, 2011
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibodyBlood, 2010
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityProceedings of the National Academy of Sciences, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3The EMBO Journal, 2007